Insmed CEO reveals Japan patient population exceeds US market for lung disease.
Share this article
Corporate
Score 75
Bullish
Insmed CEO reveals Japan patient population exceeds US market for lung disease
Mar 25, 2026 14:58 UTC
INSMD, XLV, IHF
Medium term
Related Articles
Score 45
Ace Robotics Chairman on Embodied AI, Robotics
Mar 27, 00:48
Score 65
Bullish
TDR, I Squared Are Said to Select Banks for Aggreko’s US IPO
Mar 27, 00:26
Score 65
Bullish
Fund That Bet Big on Samsung Pushes for ADRs to Raise Valuation
Mar 27, 00:24
Score 65
Bullish
RoboSense CEO On Why Digital LiDAR Has Cost Advantage
Mar 27, 00:00
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.